Low-Dose Adjuvant Aspirin Decreases Incidence of Recurrence Among Patients with Resected PI3K-Altered CRC By Ogkologos - September 30, 2025 226 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ALASCCA study Source RELATED ARTICLESMORE FROM AUTHOR Daraxonrasib Shows Antitumour Activity Among Patients with Previously Treated RAS-mutated Pancreatic Ductal Adenocarcinoma FDA Approves Vepdegestrant for ER-positive, HER2-negative, ESR1-mutated Advanced or Metastatic Breast Cancer Aiming to support a robust regulatory ecosystem for driving cancer research in Europe, ESMO provides feedback to the public consultation on dataset descriptions under... MOST POPULAR Overcoming a Cancer Nemesis? KRAS Inhibitor Shows Promise in Early Trial December 5, 2019 FDA Approves Capmatinib for Metastatic NSCLC August 29, 2022 Efficacy of Tivozanib Monotherapy in the Post-ICI Setting Among Patients with... October 9, 2024 ESMO Launches First Congress on Artificial Intelligence and Digital Oncology: A... November 12, 2025 Load more HOT NEWS 20 Adorable Tiny Homes That Are Perfect For A Peaceful Weekend... These Triplets Were Tired Of Being Mistaken For Each Other. Their... Five Questions with…Fred. Many Men with Metastatic Prostate Cancer Are Not Getting the Recommended...
